Stroke, Vol 15, 816-822, Copyright © 1984 by American Heart Association
T Yanagihara and HW Wahner
In order to evaluate cerebral blood flow (CBF) patterns among individual
patients with increased statistical confidence, CBF measurements were
carried out using the 133Xe-inhalation method and external head detectors.
F1 values representing gray matter flow from 3 to 6 head detectors were
averaged to form 16 different regions for each cerebral hemisphere.
Normative values were obtained from 46 healthy volunteers, and data from
individual regions were analyzed for absolute blood flow rates
(ml/100g/min), for concordance between right and left hemispheres and as
percent of mean hemispheric flow. CBF measurements were then carried out
among 37 patients with cerebrovascular occlusive diseases, and results were
compared with normative values. A high incidence of abnormal flows were
detected among symptomatic patients with intracranial arterial stenosis or
occlusion and those with extracranial internal carotid artery occlusion. By
using the above method for data analysis, it was possible to delineate
hypoperfused areas among these patients. Even though the 133Xe-inhalation
method has inherent limitations, this is a practical and safe method for
measurement of CBF which can provide reliable information useful for
management of patients with cerebrovascular occlusive diseases,
particularly when the results are presented with statistical confidence.
ARTICLES
Cerebral blood flow measurement in cerebrovascular occlusive diseases
This article has been cited by other articles:
![]() |
P. Scheel, C. Ruge, U. R. Petruch, and M. Schoning Color Duplex Measurement of Cerebral Blood Flow Volume in Healthy Adults Stroke, January 1, 2000; 31(1): 147 - 150. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. L. Levine, J. M. Rozental, and R. J. Nickles Blood Flow Asymmetry in Carotid Occlusive Disease Angiology, February 1, 1992; 43(2): 100 - 109. [Abstract] [PDF] |
||||
![]() |
D. C. Costa Single photon emission tomography (SPET) with 99Tc m-hexamethylpropyleneamineoxime (HMPAO) in research and clinical practice - a useful tool Vascular Medicine, September 1, 1990; 1(2): 179 - 201. [PDF] |
||||
|
Stroke Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1984 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |